Provides a blockchain-based platform that enables secure, compliant sharing and monetization of personal health data between patients, healthcare providers, and life science companies. This system streamlines post-market research, patient engagement, and real-world evidence generation, improving cohort identification, treatment adherence, and market access for novel therapies.
Funding
$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
SCFounders
Product
Problem
Sharing and monetizing personal health data is often insecure and non-compliant, hindering effective collaboration between patients, healthcare providers, and life science companies. This fragmented ecosystem complicates post-market research, limits patient engagement, and slows the generation of real-world evidence needed for therapy development and market access.
Solution
Longenesis provides a digital platform that facilitates secure and compliant exchange of patient health data among patients, healthcare providers, and life science organizations. The platform streamlines patient engagement, enhances cohort identification for research, and supports the generation of real-world evidence to improve treatment adherence and market access for innovative therapies. By bridging the gap between stakeholders, Longenesis enables patient-centric solutions that drive behavior change and accelerate market success in specialized therapeutic areas such as cardiometabolic health, oncology, infectious diseases, and women's health.
Target Audience
The primary customers are biopharma/biotech companies, hospitals, medical device companies, CROs, and academic institutions seeking to improve patient engagement, streamline research, and accelerate market access for novel therapies.
Features
- Digital patient journeys to improve disease management and build long-term relationships.
- Tools for quick and targeted patient cohort identification for novel drug therapies and research activities.
- Capabilities to launch population engagement projects to improve market uptake of innovative products.
- Generation of Real-World Evidence and Quality of Life data to support reimbursement negotiations.
- GDPR, ISO/IEC 27001, and ISO/IEC 27701 certifications ensuring data protection and privacy.